This link takes you to Probity Medical Research's website dedicated to patients called ResearchTrials.org. You will be re-directed in five seconds. If you are not re-directed click here.
Centro Internacional de Estudios Clínicos (CIEC) 343 Manzano St, office 410. Recoleta
Specialty: Dermatology |
Research Interests: Acne, Actinic Keratoses, Alopecia, Atopic Dermatitis, Basal Cell Carcinoma, Hand Dermatitis, Melanoma, Psoriasis, Rosacea
Dr. Valenzuela is a dermatologist in Santiago, Chile.
Valenzuela F, de la Cruz Fernandez C, Galimberti RL, Gürbüz S, McKean-Matthews M, Goncalves L, Romiti R. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study. Actas Dermosifiliogr 2017 Jul - Aug; 108(6): 550-63. Epub 2017 Mar 23. PMID: 28342534 / doi: 10.1016/j.ad.2017.02.005 |
Lobos N, Wortsman X, Valenzuela F, Alonso F. Color Doppler ultrasound assessment of activity in keloids. Dermatol Surg 2017 Jun; 43(6): 817-25. PMID: 28195846 / doi: 10.1097/DSS.0000000000001052 |
de la Cruz C, de Carvalho AV, Dorantes GL, Londoño Garcia AM, Gonzalez C, Maskin M, Podoswa N, Redfern JS, Valenzuela F, van der Walt J, Romiti R. Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America. J Dermatol 2017 Jan; 44(1): 3-12. Epub 2016 Jul 27. PMID: 27461455 / doi: 10.1111/1346-8138.13512 |
Valenzuela F, Paul C, Mallbris L Tan H Papacharalambous J. Valdez H, Mamolo C. Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study. J Eur Acad Dermatol Venereol 2016 Oct; 30(10): 1753-9. Epub 2016 Jun 7. PMID: 27271195 / doi: 10.1111/jdv.13702 |
Chouela E, Amaya M, Londoño A, Romiti R, Valenzuela F, Duarte A, Perez Alfonzo R, Borlenghi C. Psoriasis in Latin America. Dermatology Online Journal 2016 Sep; 22(9). doi: doj_32495 |
Valenzuela F, Lahfa M, Tan H, Papacharalambous J,Mamolo C. Tofacitinib or etanercept versus placebo on patient-reported outcomes: results from a phase 3 study in moderate to severe chronic plaque psoriasis. J Clin Aesthet Dermatol 2015; 8(5 Suppl 2): S19 |
Bachelez H, van de Kerkhof PC, Strohal R, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papcharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R, OPT Compare Investigators. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. Lancet 2015 Aug 8; 386(9993): 552-61. Epub 2015 Jun 4. PMID: 26051365 / doi: 10.1016/S0140-6736(14)62113-9 |
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 2015 Aug 8; 386(9993): 541-51. Epub 2015 Jun 10. PMID: 26072109 / doi: 10.1016/S0140-6736(15)60125-8 |
Valenzuela F, Papp KA, Pariser D, Tyring SK, Wolk R, Buonanno M, Wang J, Tan H, Valdez H. Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis. BMC Dermatol 2015 May; 15(1): 8. PMID: 25951857 / doi: 10.1186/s12895-015-0025-y |
Wortsman X, Claveria P, Valenzuela F, Molina MT, Wortsman J. Sonography of acne vulgaris. J Ultrasound Med 2014 Jan; 33(1): 93-102. PMID: 24371103 / doi: 10.7863/ultra.33.1.93 |
Waissbluth M, Kaplan V, Alegría, C, Valenzuela F, Morales C. Angiomatosis bacilar, reporte de un caso. Piel 2013 Nov; 28(9): 557-8. Epub 2013 Jun 15. |
Calderón P, Valenzuela F. International Dermatology. Dermatology in Chile. EADV News 2013; 47: 15. |
Valenzuela F, Papp K, Pariser D, Tyring S,Wolk R, Buonanno M, Valdez H. Tofacitinib has no clinically significant effects on cells controlling chronic viral infection and reactivation. J Invest Dermatol 2013; 133(S1): S17. doi: http://dx.doi.org/10.1038/jid.2013.95 |
Orellana M, Yáñez V, Hidalgo G, Valenzuela F, Saavedra R. 5% Lidocaine Medicated Plaster Use in Children with Neuropathic Pain from Burn Sequelae. Pain Med 2013 Mar; 14(3): 422-9. Epub 2012 Dec 28. PMID: 23279572 / doi: 10.1111/pme.12020 |
Valenzuela F, Yáñez V, Hidalgo G, Orellana M, Romero W. Manejo tópico de la hiperpigmentacion en secuelas de quemaduras. Piel 2013 Apr; 28(4): 215-19 |
Orellana M, Yáñez V, Gutierrez J, Hidalgo G, Valenzuela F. Prurito Neuropático. Revista El Dolor 2012 Jul; 57: 28-32 |
Valenzuela F, Valenzuela Y, Zemelman V. Epidemiological survey of psoriasis in the Chilean Mapuche population. Int J Dermatol 2012 Aug; 51(8): 1005-6. Epub 2012 Jul 12. PMID: 22788823 / doi: 10.1111/j.1365-4632.2010.04682.x |
Calderón P, Silva P, Valenzuela F. Pioderma gangrenoso en paciente con colitis ulcerosa tratada con infliximab. Rev Chilena Dermatol 2011; 27(1): 199-202 |
Valenzuela F, Silva P, Valdés M, Papp K. Epidemiology and quality of life of patients with psoriasis in Chile. Actas Dermosifiliogr 2011 Dec; 102(10): 810-16. Epub 2011 Jun 12. PMID: 21664589 / doi: 10.1016/j.ad.2011.03.022 |
Recavarren M, Zemelman V, Valenzuela F, Valdés P, Espinoza M. Síndrome metabólico en Pacientes Psoriáticos en el Hospital Clínico de la Universidad de Chile. Rev. Chilena Dermatol 2010; 26(3): 259-63 |
Papp K, Valenzuela F, Poulin Y, Bernstein G, Wasel N. Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed population. J Cutan Med Surg 2010 Jul-Aug; 14(4): 167-74. PMID: 20642985 |
Saavedra T, Valenzuela F, Figueroa A, Alarcón R. Cuál es su diagnóstico: Leishmaniasis. Rev. Chilena Dermatol 2009; 25(4): 369-72 |
Valenzuela F, Saavedra D, Zemelman V. Museo de cera: una forma de enseñanza de la sífilis en Chile a principios del siglo XX. Rev Hosp Clin Univ Chile 2009; 20: 28-32 |
Fuenzalida H, Valenzuela F, Misad C. Nodular Amyloidosis. Two clinical case reports. Clin Exp Dermatol 2009 Jan; 34(1): 92-4. Epub 2008 Dec 8. PMID: 19076805 / doi: 10.1111/j.1365-2230.2008.02927.x |
Saavedra T, Valenzuela F, Wortsman X, Carreño L. Caso clínico: Síndrome de Baboon secundario a cuerpo extraño cutáneo. Rev Hosp Clin Univ 2008; 19: 162-5 |
Zemelman V, Chávez F, Valenzuela F, Carreño L, Sazunic I. Heterogeneidad Histológica Intratumoral del Carcinoma Basocelular. Rev. Chilena Dermatol 2008; 24(1): 23-7 |
Calderón P, Valenzuela F, Carreño L, Madrid A. A possible link between cow milk and recurrent aphthous stomatitis (Letters to the editor). J Eur Acad Dermatol Venereol 2008 Jul; 22(7): 898-9. Epub 2008 Jan 10. PMID: 18194234 / doi: 10.1111/j.1468-3083.2007.02542.x |
Fuenzalida H, Valenzuela F, Segovia L. Pápulas céreas en cara anterior de piernas. Piel 2008 Apr; 23(4): 198-200. doi: 10.1016 / S0213-9251 (08) 71013-X |
Saavedra T, Valenzuela F, Veloz M, Wortsman X. Reacción alérgica sistémica al níquel secundaria a cuerpo extraño cutáneo. Piel 2007 Oct; 22(8): 417 |
LeBert M, Prado B, Valenzuela F. Leuconiquia (caso clínico). Rev Chil Dermatol 2007; 23: 152 |
Valenzuela F, Saavedra D, Roizen V. Tetraciclinas y Esmalte dental. Review. Rev Chil Dermatol 2007; 23(4): 291-6 |
Fuenzalida H, Valenzuela F. Acné vulgar desde una perspectiva evolutiva. Rev Chil Dermatol 2007; 23: 46-51 |
Valenzuela F, Saavedra T. Púrpura de Schönlein-Henoch en adulto (caso clínico). Rev Chil Dermatol 2006; 22: 276 |
Copyright 2014 Probity Medical Research Inc. All Rights Reserved.